Efficacy and safety of low‐dose oral lenalidomide in refractory cutaneous lupus erythematosus: an open series of 19 cases - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Journal of the European Academy of Dermatology and Venereology Année : 2021

Efficacy and safety of low‐dose oral lenalidomide in refractory cutaneous lupus erythematosus: an open series of 19 cases

(1, 2) , (1, 2) , (3) , (4) , (1, 2) , (1) , (3) , (1, 2)
1
2
3
4
Fichier non déposé

Dates et versions

hal-03368935 , version 1 (07-10-2021)

Identifiants

Citer

V. Reymann, D. Bessis, B. Bergeret, D. Lipsker, A. Du-Thanh, et al.. Efficacy and safety of low‐dose oral lenalidomide in refractory cutaneous lupus erythematosus: an open series of 19 cases. Journal of the European Academy of Dermatology and Venereology, 2021, 35 (2), pp.e113-e115. ⟨10.1111/jdv.16839⟩. ⟨hal-03368935⟩
13 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook Twitter LinkedIn More